Moreno, Christof T.
HRN: 18-61-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/27/2024
11/06/2024
PO
200 Mg / 8ml
Q 8 Hours
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes